Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Humanized anti-IL-6 antibody shows good efficacy and safety as rheumatoid arthritis Rx

Dec. 28, 1998

Oral human immunoglobulin proves to be safe and effective treatment for RA

Dec. 23, 1998

Design of potent MAP kinase p38 inhibitors reported by R.W. Johnson

Dec. 23, 1998

Patent assigned to Sumitomo describes new compounds for immune and inflammatory disorders

Dec. 23, 1998

Immune Response announces phase IIb trial results for RA

Dec. 23, 1998

New cell adhesion inhibitors in development at Lilly for inflammatory disorders, etc.

Dec. 22, 1998

Another group of MMP inhibitors discovered at Hoechst

Dec. 22, 1998

Compounds for inhibiting matrix metalloproteinases in development at Hoechst Marion Roussel

Dec. 21, 1998

Boehringer Ingelheim submits U.S. NDA for osteoarthritis treatment

Dec. 18, 1998

MMP inhibitors synthesized and evaluated for biological activity at Hoechst Marion Roussel

Dec. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...